JAK1 and hepatocellular carcinoma: demonstrated that IL-6-activated JAK1 phosphorylates PD-L1, which recruited endoplasmic reticulum-associated N-glycosyltransferase STT3A to catalyze glycosylation of PD-L1 and maintain PD-L1 stability in hepatocellular carcinoma (37).